The bill creates a personal income tax credit equal to qualified out‑of‑pocket in vitro fertilization (IVF) expenses, capped at $5,000 per taxpayer per taxable year, for taxable years within the bill's operative window. It limits eligibility by adjusted gross income and excludes costs covered by insurance; claiming the credit requires reducing any related deduction by the credit amount.
The Franchise Tax Board (FTB) must report on the number and value of credits allowed, and the provision sunsets after the stated operative period.
This matters for compliance officers, tax teams at fertility clinics, and state budget analysts because it directly affects taxpayer eligibility, reporting obligations for FTB, and the state's fiscal exposure. The bill uses inclusive language about who may incur IVF costs (taxpayer, spouse, surrogate) and lists multiple types of covered procedures and supports, but the text contains duplicated year references and ambiguous reporting deadlines that will affect implementation unless clarified.
At a Glance
What It Does
The bill allows a credit against 'net tax' for qualified, uninsured IVF expenses up to $5,000 per taxable year; taxpayers must reduce any deduction for those same expenses by the credit amount. It defines an enumerated set of covered procedures and supporting costs.
Who It Affects
Individual taxpayers who incur out‑of‑pocket IVF costs and whose adjusted gross income falls at or below the bill’s means thresholds, fertility clinics and their billing/compliance teams, and the Franchise Tax Board for administration and reporting.
Why It Matters
The measure creates a narrowly targeted fiscal subsidy for IVF that is means‑tested and time‑limited, which changes taxpayer behavior, may increase demand for clinic services, and creates a measurable fiscal cost that FTB must track and report.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
As written, the bill creates a tax credit that taxpayers can claim against their net California personal income tax for qualified expenses tied to in vitro fertilization. The credit is capped at $5,000 per taxable year and applies only to expenses not already covered by insurance.
The statutory language explicitly lists a wide range of procedures and related supports that qualify, from preparatory testing through embryo transfer and posttransfer monitoring, and includes medications and sperm preparation.
Eligibility is limited by adjusted gross income: married taxpayers filing jointly who are 'surviving spouse or spouses' (language in the bill) have a higher AGI threshold than other individuals. The bill also requires that if a taxpayer claims this credit, they must reduce any deduction for the same IVF costs by the amount of the credit, preventing a taxpayer from doubly benefiting through both a deduction and the credit for the same expense.The Franchise Tax Board must measure performance using two metrics—number of taxpayers claiming the credit and total dollar value of credits allowed—and report those figures to the Legislature on the schedule stated in the bill.
The bill treats those reporting disclosures as an exception to a specified confidentiality statute. Finally, the credit is time‑limited: the statute contains operative start and end dates and a stated repeal date, although the text duplicates year references in several places, creating ambiguity about the exact effective window and reporting deadlines that will need to be resolved in practice.
The Five Things You Need to Know
The credit equals qualified uninsured IVF expenses up to $5,000 per taxable year, claimed against the 'net tax.', The bill enumerates qualifying costs — including testing, ovarian stimulation, egg retrieval, fertilization, embryo transfer, monitoring, sperm preparation, and prescribed medications — as eligible expenses.
Eligibility is means‑tested: joint filers described as 'surviving spouse or spouses' must have AGI ≤ $300,000; other individuals must have AGI ≤ $150,000.
If a taxpayer claims the credit, they must reduce any income tax deduction for the same IVF expense by the amount of the credit.
The Franchise Tax Board must report to the Legislature on the number of credits allowed and total dollar value (with specific reporting dates in the text), and the section contains a statutory sunset/repeal date.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Credit allowed and dollar cap
This subsection creates the core tax preference: a credit against 'net tax' for qualified IVF expenses not to exceed $5,000 per taxable year. Practically, this establishes the maximum per‑taxpayer annual subsidy and identifies the credit as a component that reduces tax liability rather than a refundable payment. Compliance systems will need to add a new line for this credit and enforce the per‑year cap.
Definition of qualified expenses — enumerated list
The bill defines 'qualified expenses of in vitro fertilization' with an explicit, non‑exhaustive list of covered items, ranging from preparatory testing to embryo transfer and posttransfer monitoring, plus medications and sperm preparation. That level of specificity narrows administrative discretion but also requires FTB and taxpayers to interpret medical billing codes and receipts to determine which items fit the statutory list.
Definition of qualified taxpayer and AGI thresholds
This subsection establishes means limits tied to adjusted gross income: a higher threshold applies for 'surviving spouse or spouses' filing a joint return ($300,000) and a lower threshold for all other individuals ($150,000). The phrasing introduces potential ambiguities (for example, how 'surviving spouse' is to be applied for eligibility) that will affect claim validation and may require FTB guidance or rulemaking to administer consistently.
Interaction with deductions
The bill prevents double tax benefit by requiring taxpayers who take the credit to reduce any otherwise allowable deduction for the same IVF costs by the credit amount. That creates an administrative requirement to track expense allocations between credits and deductions and likely increases recordkeeping and audit focal points — for both taxpayers and FTB.
Reporting requirements, confidentiality exception, and sunset
The Legislature sets two performance indicators (number of taxpayers claiming the credit and total dollar value) and directs FTB to report to the Legislature on a specified schedule. The bill treats those disclosures as an exception to a confidentiality statute, meaning FTB can release aggregate data. It also includes a repeal/sunset provision with a stated date; however, the text contains duplicate and conflicting year references for the operative period and reporting deadlines that will complicate practical implementation unless clarified.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Lower‑ and moderate‑income IVF patients with uninsured costs: Individuals or couples whose AGI falls under the statutory thresholds and who pay out‑of‑pocket for IVF procedures will receive up to $5,000 tax relief per taxable year, directly lowering their tax liability for the year they incur costs.
- Surrogates and spouses whose procedures are billed to the taxpayer: The statute explicitly covers IVF procedures undergone by the taxpayer, the taxpayer’s spouse, or the taxpayer’s surrogate, meaning intended parents using surrogacy arrangements can potentially claim the credit for associated out‑of‑pocket costs.
- Fertility clinics and associated providers: Increased affordability may raise demand for services, improving clinic revenue and justifying investments in billing and compliance processes to help patients document eligible expenses.
Who Bears the Cost
- State general fund / taxpayers: The credit reduces state tax receipts to the extent taxpayers claim it; the fiscal impact depends on take‑up and average credit amounts, which the bill requires FTB to report but does not cap in aggregate.
- Franchise Tax Board (administration): FTB must establish new claim processing, validation practices for medical expenses, reporting procedures, and handle confidentiality exceptions — all of which create administrative workload and potential one‑time and ongoing costs.
- Taxpayers and clinics for documentation and compliance: Taxpayers must maintain detailed receipts and providers may need to supply clearer billing descriptions; the required deduction adjustment also increases bookkeeping complexity and potential audit exposure for taxpayers.
Key Issues
The Core Tension
The central tension is between expanding access to costly reproductive care through a targeted, means‑tested tax subsidy and the administrative and fiscal costs of doing so: tighter targeting and a nonrefundable credit reduce fiscal exposure but complicate eligibility rules, verification, and taxpayer burden; broader eligibility would simplify administration but substantially increase state cost and raise questions about the proper scope of tax‑based health subsidies.
The bill contains textual duplications and ambiguous phrasing that create real implementation questions. Multiple provisions list different years for the start and end of the operative window (e.g., 'beginning on or after January 1, 2025, 2026' and 'before January 1, 2030, 2031'), and the reporting schedule lists more than one possible date.
Those are not minor drafting typos for practitioners: they affect when taxpayers can claim the credit, which tax years FTB must evaluate, and when the statute will repeal. Absent clean legislative text, FTB would need either authoritative guidance or emergency regulations to set firm rules, and disputes could arise over claims filed in the ambiguous years.
Other unresolved operational matters include verification standards for 'qualified expenses' — the bill lists eligible items but does not prescribe documentation standards (what receipts, practitioner attestations, or billing codes suffice). The statute also does not specify refundability; by referencing 'net tax' and not stating refundability the provision appears nonrefundable, which matters to taxpayers with low or zero tax liability.
Finally, the 'surviving spouse or spouses' phrase used in the eligibility subsection is unusual and could create edge cases in timing (e.g., a decedent's final return) and in applying the higher AGI threshold, raising fairness and administrative concerns.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.